Literature DB >> 34424055

Huntingtin Polyglutamine Fragments Are a Substrate for Hsp104 in Saccharomyces cerevisiae.

Nicole J Wayne1, Katherine E Dembny1, Tyler Pease1, Farrin Saba1, Xiaohong Zhao1, Daniel C Masison2, Lois E Greene1.   

Abstract

The aggregation of huntingtin fragments with expanded polyglutamine repeat regions (HttpolyQ) that cause Huntington's disease depends on the presence of a prion with an amyloid conformation in yeast. As a result of this relationship, HttpolyQ aggregation indirectly depends on Hsp104 due to its essential role in prion propagation. We find that HttQ103 aggregation is directly affected by Hsp104 with and without the presence of [RNQ+] and [PSI+] prions. When we inactivate Hsp104 in the presence of prion, yeast cells have only one or a few large HttQ103 aggregates rather than numerous smaller aggregates. When we inactivate Hsp104 in the absence of prion, there is no significant aggregation of HttQ103, whereas with active Hsp104, HttQ103 aggregates accumulate slowly due to the severing of spontaneously nucleated aggregates by Hsp104. We do not observe either effect with HttQ103P, which has a polyproline-rich region downstream of the polyglutamine region, because HttQ103P does not spontaneously nucleate and Hsp104 does not efficiently sever the prion-nucleated HttQ103P aggregates. Therefore, the only role of Hsp104 in HttQ103P aggregation is to propagate yeast prion. In conclusion, because Hsp104 efficiently severs the HttQ103 aggregates but not HttQ103P aggregates, it has a marked effect on the aggregation of HttQ103 but not HttQ103P.

Entities:  

Keywords:  Hsp104; Huntington’s disease; amyloid; prions; yeast

Mesh:

Substances:

Year:  2021        PMID: 34424055      PMCID: PMC8547424          DOI: 10.1128/MCB.00122-21

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  69 in total

1.  A Filter Retardation Assay Facilitates the Detection and Quantification of Heat-Stable, Amyloidogenic Mutant Huntingtin Aggregates in Complex Biosamples.

Authors:  Anne Ast; Franziska Schindler; Alexander Buntru; Sigrid Schnoegl; Erich E Wanker
Journal:  Methods Mol Biol       Date:  2018

Review 2.  The emerging role of the first 17 amino acids of huntingtin in Huntington's disease.

Authors:  James R Arndt; Maxmore Chaibva; Justin Legleiter
Journal:  Biomol Concepts       Date:  2015-03

3.  Normal-repeat-length polyglutamine peptides accelerate aggregation nucleation and cytotoxicity of expanded polyglutamine proteins.

Authors:  Natalia Slepko; Anusri M Bhattacharyya; George R Jackson; Joan S Steffan; J Lawrence Marsh; Leslie Michels Thompson; Ronald Wetzel
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-15       Impact factor: 11.205

Review 4.  Insights from mouse models into the molecular basis of neurodegeneration.

Authors:  N Heintz; H Y Zoghbi
Journal:  Annu Rev Physiol       Date:  2000       Impact factor: 19.318

5.  In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease.

Authors:  C Fennema-Notestine; S L Archibald; M W Jacobson; J Corey-Bloom; J S Paulsen; G M Peavy; A C Gamst; J M Hamilton; D P Salmon; T L Jernigan
Journal:  Neurology       Date:  2004-09-28       Impact factor: 9.910

6.  A yeast TDP-43 proteinopathy model: Exploring the molecular determinants of TDP-43 aggregation and cellular toxicity.

Authors:  Brian S Johnson; J Michael McCaffery; Susan Lindquist; Aaron D Gitler
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-23       Impact factor: 11.205

7.  Flanking polyproline sequences inhibit beta-sheet structure in polyglutamine segments by inducing PPII-like helix structure.

Authors:  Gregory Darnell; Joseph P R O Orgel; Reinhard Pahl; Stephen C Meredith
Journal:  J Mol Biol       Date:  2007-09-14       Impact factor: 5.469

8.  Morphometric demonstration of atrophic changes in the cerebral cortex, white matter, and neostriatum in Huntington's disease.

Authors:  S M de la Monte; J P Vonsattel; E P Richardson
Journal:  J Neuropathol Exp Neurol       Date:  1988-09       Impact factor: 3.685

9.  Overexpression of yeast hsp104 reduces polyglutamine aggregation and prolongs survival of a transgenic mouse model of Huntington's disease.

Authors:  Coralie Vacher; Lourdes Garcia-Oroz; David C Rubinsztein
Journal:  Hum Mol Genet       Date:  2005-10-04       Impact factor: 6.150

10.  Appearance and propagation of polyglutamine-based amyloids in yeast: tyrosine residues enable polymer fragmentation.

Authors:  Ilya M Alexandrov; Aleksandra B Vishnevskaya; Michael D Ter-Avanesyan; Vitaly V Kushnirov
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

View more
  3 in total

Review 1.  The value of exosome-derived noncoding RNAs in colorectal cancer proliferation, metastasis, and clinical applications.

Authors:  Wenjie Zhang; Zhengting Jiang; Dong Tang
Journal:  Clin Transl Oncol       Date:  2022-08-03       Impact factor: 3.340

2.  Circ_0082182 upregulates the NFIB level via sponging miR-326 to promote oxaliplatin resistance and malignant progression of colorectal cancer cells.

Authors:  Zhifeng Wang; Jingmei Liu; Tao Yang; Qinqin Wang; Rong Liang; Jinliang Tang
Journal:  Mol Cell Biochem       Date:  2022-10-11       Impact factor: 3.842

3.  Hsp104 N-terminal domain interaction with substrates plays a regulatory role in protein disaggregation.

Authors:  Anna Harari; Guy Zoltsman; Tal Levin; Rina Rosenzweig
Journal:  FEBS J       Date:  2022-03-30       Impact factor: 5.622

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.